# Lamotrigine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

> **NCT00068445** · PHASE3 · COMPLETED · sponsor: **Alliance for Clinical Trials in Oncology** · enrollment: 131 (actual)

## Conditions studied

- Neurotoxicity
- Pain
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** lamotrigine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00068445
- **Lead sponsor:** Alliance for Clinical Trials in Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-02
- **Primary completion:** 2006-05
- **Final completion:** 2013-11
- **Target enrollment:** 131 (ACTUAL)
- **Last updated:** 2018-05-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00068445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00068445, "Lamotrigine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00068445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*